NCT00538304View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

222

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

bimatoprost eye drops

1 drop in each eye daily for 1 month

DRUG

placebo

1 drop in each eye daily for 1 month

Trial Locations (1)

Unknown

Atlanta

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY